A citation-based method for searching scientific literature

Nathaniel H Boyd, Anh Nhat Tran, Joshua D Bernstock, Tina Etminan, Amber B Jones, G Yancey Gillespie, Gregory K Friedman, Anita B Hjelmeland. Theranostics 2021
Times Cited: 7







List of co-cited articles
15 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
28

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
Roger Stupp, Monika E Hegi, Warren P Mason, Martin J van den Bent, Martin J B Taphoorn, Robert C Janzer, Samuel K Ludwin, Anouk Allgeier, Barbara Fisher, Karl Belanger,[...]. Lancet Oncol 2009
28

Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies.
Sameer Agnihotri, Kelly E Burrell, Amparo Wolf, Sharzhad Jalali, Cynthia Hawkins, James T Rutka, Gelareh Zadeh. Arch Immunol Ther Exp (Warsz) 2013
126
28

Genome-wide translation patterns in gliomas: An integrative view.
Glaucia Noeli Maroso Hajj, Paula Borzino Cordeiro Nunes, Martin Roffe. Cell Signal 2021
4
50

The epidemiology of glioma in adults: a "state of the science" review.
Quinn T Ostrom, Luc Bauchet, Faith G Davis, Isabelle Deltour, James L Fisher, Chelsea Eastman Langer, Melike Pekmezci, Judith A Schwartzbaum, Michelle C Turner, Kyle M Walsh,[...]. Neuro Oncol 2014
854
28

Epidemiologic and molecular prognostic review of glioblastoma.
Jigisha P Thakkar, Therese A Dolecek, Craig Horbinski, Quinn T Ostrom, Donita D Lightner, Jill S Barnholtz-Sloan, John L Villano. Cancer Epidemiol Biomarkers Prev 2014
494
28

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
Roger Stupp, Warren P Mason, Martin J van den Bent, Michael Weller, Barbara Fisher, Martin J B Taphoorn, Karl Belanger, Alba A Brandes, Christine Marosi, Ulrich Bogdahn,[...]. N Engl J Med 2005
28

Stem cells, cancer, and cancer stem cells.
T Reya, S J Morrison, M F Clarke, I L Weissman. Nature 2001
28

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.
Cyril Neftel, Julie Laffy, Mariella G Filbin, Toshiro Hara, Marni E Shore, Gilbert J Rahme, Alyssa R Richman, Dana Silverbush, McKenzie L Shaw, Christine M Hebert,[...]. Cell 2019
399
28

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.
Anoop P Patel, Itay Tirosh, John J Trombetta, Alex K Shalek, Shawn M Gillespie, Hiroaki Wakimoto, Daniel P Cahill, Brian V Nahed, William T Curry, Robert L Martuza,[...]. Science 2014
28

Intra-tumor heterogeneity from a cancer stem cell perspective.
Pramudita R Prasetyanti, Jan Paul Medema. Mol Cancer 2017
235
28

Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition.
Anna Segerman, Mia Niklasson, Caroline Haglund, Tobias Bergström, Malin Jarvius, Yuan Xie, Ann Westermark, Demet Sönmez, Annika Hermansson, Marianne Kastemar,[...]. Cell Rep 2016
96
28

Genomic instability--an evolving hallmark of cancer.
Simona Negrini, Vassilis G Gorgoulis, Thanos D Halazonetis. Nat Rev Mol Cell Biol 2010
28

The somatic genomic landscape of glioblastoma.
Cameron W Brennan, Roel G W Verhaak, Aaron McKenna, Benito Campos, Houtan Noushmehr, Sofie R Salama, Siyuan Zheng, Debyani Chakravarty, J Zachary Sanborn, Samuel H Berman,[...]. Cell 2013
28

Identification of human brain tumour initiating cells.
Sheila K Singh, Cynthia Hawkins, Ian D Clarke, Jeremy A Squire, Jane Bayani, Takuichiro Hide, R Mark Henkelman, Michael D Cusimano, Peter B Dirks. Nature 2004
28

E7070, a novel sulphonamide agent with potent antitumour activity in vitro and in vivo.
Y Ozawa, N H Sugi, T Nagasu, T Owa, T Watanabe, N Koyanagi, H Yoshino, K Kitoh, K Yoshimatsu. Eur J Cancer 2001
89
14

Multidrug resistance in glioblastoma stem-like cells: Role of the hypoxic microenvironment and adenosine signaling.
Daniel Uribe, Ángelo Torres, José Dellis Rocha, Ignacio Niechi, Carlos Oyarzún, Luis Sobrevia, Rody San Martín, Claudia Quezada. Mol Aspects Med 2017
58
14

Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy.
Alan McIntyre, Shalini Patiar, Simon Wigfield, Ji-Liang Li, Ioanna Ledaki, Helen Turley, Russell Leek, Cameron Snell, Kevin Gatter, William S Sly,[...]. Clin Cancer Res 2012
166
14

Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells.
Joanna Kopecka, Ivana Campia, Andrea Jacobs, Andreas P Frei, Dario Ghigo, Bernd Wollscheid, Chiara Riganti. Oncotarget 2015
64
14

Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion.
Bin Hu, Keerthi K Thirtamara-Rajamani, Hosung Sim, Mariano S Viapiano. Mol Cancer Res 2009
97
14

The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond.
Silvia Pastorekova, Robert J Gillies. Cancer Metastasis Rev 2019
92
14

Therapeutic potential and molecular mechanism of a novel sulfonamide anticancer drug, indisulam (E7070) in combination with CPT-11 for cancer treatment.
Yoichi Ozawa, Kazutomi Kusano, Takashi Owa, Akira Yokoi, Makoto Asada, Kentaro Yoshimatsu. Cancer Chemother Pharmacol 2012
21
14

Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment.
Andrea Angeli, Fabrizio Carta, Alessio Nocentini, Jean-Yves Winum, Raivis Zalubovskis, Atilla Akdemir, Valentina Onnis, Wagdy M Eldehna, Clemente Capasso, Giuseppina De Simone,[...]. Metabolites 2020
33
14


Carbonic anhydrase IX as a target for metastatic disease.
Roben G Gieling, Kaye J Williams. Bioorg Med Chem 2013
39
14

Selection of suitable housekeeping genes for expression analysis in glioblastoma using quantitative RT-PCR.
Valeria Valente, Silvia A Teixeira, Luciano Neder, Oswaldo K Okamoto, Sueli M Oba-Shinjo, Suely K N Marie, Carlos A Scrideli, Maria L Paçó-Larson, Carlos G Carlotti. BMC Mol Biol 2009
111
14

Modulation of carbonic anhydrase 9 (CA9) in human brain cancer.
Harun M Said, Claudiu T Supuran, Carsten Hageman, Adrian Staab, Buelent Polat, Astrid Katzer, Andrea Scozzafava, Jelena Anacker, Michael Flentje, Dirk Vordermark. Curr Pharm Des 2010
35
14


Post-radiation increase in VEGF enhances glioma cell motility in vitro.
Whoon Jong Kil, Philip J Tofilon, Kevin Camphausen. Radiat Oncol 2012
57
14

Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review.
Neha Singh, Alexandra Miner, Lauren Hennis, Sandeep Mittal. Cancer Drug Resist 2021
8
14

A randomized phase II pharmacokinetic and pharmacodynamic study of indisulam as second-line therapy in patients with advanced non-small cell lung cancer.
Denis C Talbot, Joachim von Pawel, Emma Cattell, S Murray Yule, Claire Johnston, Anthe S Zandvliet, Alwin D R Huitema, Chris J Norbury, Paul Ellis, Leon Bosquee,[...]. Clin Cancer Res 2007
37
14

Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo.
Nathaniel H Boyd, Kiera Walker, Joshua Fried, James R Hackney, Paul C McDonald, Gloria A Benavides, Raffaella Spina, Alessandra Audia, Sarah E Scott, Catherine J Libby,[...]. JCI Insight 2017
48
14

A phase I and pharmacokinetic study of indisulam in combination with carboplatin.
C Dittrich, A S Zandvliet, M Gneist, A D R Huitema, A A J King, J Wanders. Br J Cancer 2007
20
14

Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII.
Katia D'Ambrosio, Rosa-Maria Vitale, Jean-Michel Dogné, Bernard Masereel, Alessio Innocenti, Andrea Scozzafava, Giuseppina De Simone, Claudiu T Supuran. J Med Chem 2008
43
14

Phase I pharmacokinetic and pharmacogenomic study of E7070 administered once every 21 days.
Yasuhide Yamada, Noboru Yamamoto, Tatsu Shimoyama, Atsushi Horiike, Yasuhito Fujisaka, Kyoko Takayama, Terumi Sakamoto, Yuki Nishioka, Sanae Yasuda, Tomohide Tamura. Cancer Sci 2005
21
14

Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells.
K Fukuoka, J Usuda, Y Iwamoto, H Fukumoto, T Nakamura, T Yoneda, N Narita, N Saijo, K Nishio. Invest New Drugs 2001
72
14

The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia/MMP14-mediated invasion.
M Swayampakula, P C McDonald, M Vallejo, E Coyaud, S C Chafe, A Westerback, G Venkateswaran, J Shankar, G Gao, E M N Laurent,[...]. Oncogene 2017
56
14

Cancer-associated carbonic anhydrases and their inhibition.
S Pastorekova, M Zatovicova, J Pastorek. Curr Pharm Des 2008
130
14

Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme.
Yasushi Soda, Chad Myskiw, Amy Rommel, Inder M Verma. J Mol Med (Berl) 2013
97
14

New strategies for targeting the hypoxic tumour microenvironment in breast cancer.
Carol Ward, Simon P Langdon, Peter Mullen, Adrian L Harris, David J Harrison, Claudiu T Supuran, Ian H Kunkler. Cancer Treat Rev 2013
132
14

Influence of hypoxia-dependent factors on the progression of neuroblastoma.
Helen M Ameis, Astrid Drenckhan, Morton Freytag, Jakob R Izbicki, Claudiu T Supuran, Konrad Reinshagen, Stefan Holland-Cunz, Stephanie J Gros. Pediatr Surg Int 2016
11
14

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.
Roger Stupp, Pierre-Yves Dietrich, Sandrine Ostermann Kraljevic, Alessia Pica, Ivan Maillard, Phillipe Maeder, Reto Meuli, Robert Janzer, Gianpaolo Pizzolato, Raymond Miralbell,[...]. J Clin Oncol 2002
588
14


Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness.
Carol Ward, James Meehan, Mark Gray, Ian H Kunkler, Simon P Langdon, David J Argyle. Metabolites 2018
27
14

Response of CAIX and CAXII to in vitro re-oxygenation and clinical significance of the combined expression in NSCLC patients.
Marius Ilie, Véronique Hofman, Joséphine Zangari, Johanna Chiche, Jérôme Mouroux, Nathalie M Mazure, Jacques Pouysségur, Patrick Brest, Paul Hofman. Lung Cancer 2013
15
14

Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
Yuanmei Lou, Paul C McDonald, Arusha Oloumi, Stephen Chia, Christina Ostlund, Ardalan Ahmadi, Alastair Kyle, Ulrich Auf dem Keller, Samuel Leung, David Huntsman,[...]. Cancer Res 2011
490
14

Glioma cell migration on three-dimensional nanofiber scaffolds is regulated by substrate topography and abolished by inhibition of STAT3 signaling.
Paula A Agudelo-Garcia, Jessica K De Jesus, Shante P Williams, Michal O Nowicki, Ennio Antonio Chiocca, Sandya Liyanarachchi, Pui-Kai Li, John J Lannutti, Jed K Johnson, Sean E Lawler,[...]. Neoplasia 2011
77
14

Antitumor efficacy of a monoclonal antibody that inhibits the activity of cancer-associated carbonic anhydrase XII.
Gabor Gondi, Josef Mysliwietz, Alzbeta Hulikova, Jian Ping Jen, Pawel Swietach, Elisabeth Kremmer, Reinhard Zeidler. Cancer Res 2013
35
14

Molecular mechanisms of temozolomide resistance in glioblastoma multiforme.
Tor-Christian Aase Johannessen, Rolf Bjerkvig. Expert Rev Anticancer Ther 2012
86
14

Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy.
Bin Wang, Qin Zhao, Yuyu Zhang, Zijing Liu, Zhuangzhuang Zheng, Shiyu Liu, Lingbin Meng, Ying Xin, Xin Jiang. J Exp Clin Cancer Res 2021
26
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.